Teclison

About:

Teclison is to develop new drugs to treat cancer and other diseases with strong unmet medical needs.

Website: http://teclison.com/

Top Investors: Nestor Capital, WTT Investment

Description:

Teclison is to develop new drugs to treat cancer and other diseases with strong unmet medical needs.

Total Funding Amount:

$5.9M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Montclair, New Jersey, United States

Founded Date:

2014-01-01

Contact Email:

info(AT)teclison.com

Founders:

Ray Lee

Number of Employees:

11-50

Last Funding Date:

2022-02-14

IPO Status:

Private

Industries:

© 2025 bioDAO.ai